富含亮氨酸重复结构域蛋白9抗体
LRR and PYD domains-containing protein 9; NACHT; NACHT, LRR and PYD domains-containing protein 9; NALP9_HUMAN; NLRP9; Nucleotide-binding oligomerization domain protein 6; PYRIN and NACHT-containing pr
磷酸化谷氨酸受体2B抗体
NMDAR2B (Phospho-Tyr1474); NMDAR2B (Phospho-Y1474); p-NMDAR2B (Tyr1474); p-NMDAR2B (Y1474); AW490526; Glutamate [NMDA] receptor subunit epsilon 2; Glutamate [NMDA] receptor subunit epsilon-2; Glutamat
原钙粘附蛋白12/血管内皮钙粘蛋白2抗体
PCD12_HUMAN; Pcdh12; Protocadherin 12; Protocadherin-12; Vascular cadherin 2; Vascular cadherin-2; Vascular endothelial cadherin 2; Vascular endothelial cadherin-2; VE cadherin 2; VE-cad-2; VE-cadheri
腺苷酸环化酶1抗体
3'5' cyclic AMP synthetase; ADCY1; adenyl cyclase; Adenylate cyclase 1; adenylate cyclase type I; ATP pyrophosphate lyase; Brain adenylate cyclase 1; Ca(2+)/calmodulin activated adenylyl cyclase; EC 4
Anti-CP110 Polyclonal Antibody
Anti-CP110 Polyclonal Antibody 应用 IHC 稀释比例 IHC 1:50-200. 交叉反应 Human